Science Explorer Interactive view Map
Company · Shelton · United States

Centrix (United States)

Research works
4
▲ 400% vs 2013–17
Citations
4
1.0 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
12%
world 28%

Not ranked overall: Centrix (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Centrix (United States) publish most on?

By volume in 2022–2025: Global Cancer Incidence and Screening, Advances in Oncology and Radiotherapy, BRCA gene mutations in cancer and Primary Care and Health Outcomes.

  1. 1 Global Cancer Incidence and Screening Oncology 0 works
  2. 2 Advances in Oncology and Radiotherapy Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 BRCA gene mutations in cancer Genetics 0 works
  4. 4 Primary Care and Health Outcomes General Health Professions 0 works
  5. 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  6. 6 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
  7. 7 Acute Myocardial Infarction Research Cardiology and Cardiovascular Medicine 0 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available11.9%not open88.1%

World: 28% of research is openly available.

with international co-authors4.8%domestic only95.2%

World: 19% is written across borders.

Other research institutions in Shelton

All research institutions in Shelton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.